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Background: Rabies causes an acute fatal encephalomyelitis in most mammals following infection with
rhabdovirus of the genus Lyssavirus. Little is known about rabies virus infection in species of New World
non-human Primates (NHP). To investigate the suitability of the owl monkey Aotus nancymaae asissue sections
examined were unremarkable for inflammation or other histologic signs of rabies a viable animal model for rabies
virus candidate vaccine testing, we used clinical presentation, serology, viral isolation, and PCR to evaluate the
incubation period, immunity, and pathogenesis of infected animals. We tested the hypothesis that no viremic state
exists for rabies virus.
Methods: Eight monkeys divided into two equal groups were inoculated intramuscularly either in the neck or
footpad with 105 pfu of rabies virus (Pasteur/V-13R) and observed for >130 days. Oral and blood samples were
collected and analyzed.
Results: Two monkeys inoculated in the neck displayed classic paralytic rabies. The mean incubation period was
11.5 days. The average maximum IgG response (antibody titer >0.200 O.D.) was achieved at day 10.0 and 62.3 in
the clinical rabies and non-clinical rabies cases, respectively (p = 0.0429). No difference in IgM or IgG time to
seroconversion or average maximum IgM level was observed between neck versus footpad inoculation groups. No
viremia or viral shedding was detected by PCR or viral isolation during the observation period, including within the
two symptomatic animals three days after disease onset. Tissue sections examined were unremarkable for
inflammation or other histologic signs of rabies within the asymptomatic animal. Similarly none of the brain
sections exhibited immunoreactivity for rabies virus antibody.
Discussion: This study demonstrates there is no difference in time to immune response between inoculation sites
and distance to the brain; however, immune response tends to be more rapid in cases of clinically apparent disease
and prolonged in cases infected at sites further from the brain.
Conclusions: Our findings support the hypothesis that a viremic state for rabies does not exist in the New World
Monkey, Aotus nancymaae, and it appears that this species may be refractory to infection. The species does provide
a suitable model to assess post infection immune responses. Additional studies that address the limitations of
sample size, length of observation, and lack of measurable infection should be conducted.
Keywords: Rabies, Rhabdovirus, Lyssavirus, Incubation period, Viremia, Monkey, Aotus nancymaae, Non-human
Primate, Ante mortem, Vaccine* Correspondence: ztq9@cdc.gov
1Naval Medical Research Unit No. 6, Av. Venezuela cdra. 36 s/n, Callao 2, Peru
Full list of author information is available at the end of the article
© 2012 Reaves et al.; The article is a work of the United States Government; licensee BioMed Central Ltd. This is an Open Access
article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reaves et al. Virology Journal 2012, 9:95 Page 2 of 9
http://www.virologyj.com/content/9/1/95Background
Rabies virus, a rhabdovirus of the genus Lyssavirus,
causes an acute fatal encephalomyelitis. All mammals
are susceptible to the disease, but this may be influenced
by the viral strain. Worldwide there are an estimated
24,000 to 90,000 human deaths per year, primarily in
developing countries, with the largest burden occurring
in Asia and Africa [1]. The primary route of transmis-
sion has long been established as contact with saliva
from an infected animal, usually through a bite or
scratch. The virus spreads by replicating its RNA using a
reverse transcriptase and traveling primarily via the per-
ipheral nervous system (PNS) to access the central ner-
vous system (CNS) and numerous other organs [2]. The
incubation period in humans ranges from 3–12 weeks
but is thought to be as long as 7 years, depending on
wound severity, wound site in relation to nerve supply
and distance from the brain, and amount and strain of
the virus [3]. The disease manifests as paresis and par-
alysis, convulsions, and ultimately death, usually due to
respiratory paralysis. Wild and domestic animals can
serve as reservoirs for the virus. In developing countries,
dogs remain the principal reservoir [1] although contact
with infected bats is becoming more common [4-9]. Six
cases of human rabies spread through marmosets reared
as pets occurred in Brazil from 1989–1996 [10]. In the
Brazilian state of Ceará, an average of 25 persons per
month seek rabies post-exposure prophylaxis for mar-
moset and other non-human primate (NHP) bites
[11,12]. During 2004–2006 the National Institute of
Health in Peru reported six cases of human rabies from
contact with monkeys, which are often kept as pets [13].
In this context, rearing of wild animals such as mon-
keys is a growing concern by the Peruvian Ministry of
Health for rabies control. There is currently no
established protocol or recommendation regarding pre-
exposure rabies immunization of wild fauna outside of
its natural habitat [14]. Appropriate rabies prophylaxis
should be evaluated and considered for such animals
that are often maintained outside as pets where expos-
ure to terrestrial wildlife carnivores or bats is exceed-
ingly possible and most likely unwitnessed [15].
Preventive therapy could potentially preclude human
cases and the needless sacrifice of animals, many of
which are protected by the Convention on International
Trade in Endangered Species of Wild Fauna and Flora
(CITES). However, an incubation period and a protective
level of rabies neutralizing antibody has not been estab-
lished for non-human primates, including New World
species, nor has a vaccine product been licensed. Little is
known about rabies virus infection in species of New
World NHP, rather the majority of work in non-human
primates has been conducted in Old World NHP, specif-
ically in Rhesus monkeys. New World NHP, Aotusnancymaae, commonly known as owl monkeys, poten-
tially provide a useful preclinical safety and immunogen-
icity model [16]. These animals have been shown to be
useful as animal models for various other pathogens.
There has been controversy on whether a viremia
exists with rabies infection in other animal species, but
this hypothesis has yet to be tested in New World NHP.
Reports of infection in other mammals seem to suggest
viremia does not occur in natural infection [17,18] mak-
ing the presence of a viremic state among human cases a
contested issue [19]. In a study of rabies infected mice,
viremia was detected in 84% of cases that developed
clinical illness 11–16 days post-inoculation[20]. In
addition, 52% of these clinically ill mice had detectable
neutralizing antibody, partially refuting the claim that
neutralizing antibody completely masks viremia [21].
Viremia has also been detected in the leucocytes of clin-
ically ill rabbits [22].
Unlike other animal studies, the frequency of salivary
gland infection in naturally-infected New World NHP is
unknown. Ante mortem diagnosis of rabies has been
reported in humans by using PCR for virus detection in
but this is yet to be evaluated in monkeys [23-25]. While
traditional screening tests such as rabies tissue culture
inoculations tests and mouse inoculations tests gave
negative results, RT-PCR was able to detect virus in sal-
iva [24]. One study demonstrated that 5 out of 9 saliva
samples from human cases were RT-PCR positive for ra-
bies [23]. An additional study using nested RT-PCR
detected virus in 9 saliva samples from 24 cases. This
particular study showed that the nested RT-PCR was
more sensitive than conventional RT-PCR techniques
(75% sensitivity versus 37%) and is a useful ante mortem
diagnostic tool [25].
The purpose of this study is to use A. nancymaae as
an animal model to 1) observe the incubation period of
the virus in this species, 2) determine the presence of a
viremic state after infection, and 3) evaluate if PCR on
saliva is an effective ante mortem diagnostic method.
The results of these evaluations will be used in future
studies to determine the effectiveness of various rabies
vaccines in New World NHP and establish a protocol
for these and related species. Live virus challenge for
candidate vaccine testing presents advantages to simul-
taneously test the hypothesis that a viremic state does
not exist in New World NHP and to explore the devel-
opment of an effective ante mortem diagnostic test.
Results
Clinical disease and mortality
All monkeys were antibody negative for rabies virus by
ELISA and without clinical rabies prior to the study chal-
lenge. Two of eight monkeys exhibited classic clinical rabies
(neurologic paresis, convulsions, and wild, irrational
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1600 developed clinical rabies 10 days post-inoculation and
was euthanized on day 12. Animal 1938 developed clinical
rabies 13 days post-inoculation and was euthanized on day
15. Both subjects were female and inoculated in the neck.
The remaining six monkeys exhibited no signs or symp-
toms of clinical rabies and were euthanized at the termin-
ation of the study on day 134 post-inoculation.Virus detected by PCR
Results of the serum and saliva RT-PCR were negative
for all monkeys before inoculation and throughout the
observation period post-inoculation. Furthermore, no
viral shedding was observed in either of the clinically ill
monkeys during the three day observation period follow-
ing onset of symptoms.Antibody response to rabies virus inoculation
Anti-rabies antibody responses by IgM and IgG ELISA
optical density (O.D.) were compared between the clin-
ical rabies cases and non-clinical rabies cases and be-
tween sites of inoculation (neck and footpad). The
average onset time for an antibody response was deter-
mined to be the first day post-inoculation for which
antibody titer (>0.200 O.D.) was detected. The daily
IgM and IgG antibody responses post-inoculation in
both the neck and the footpad inoculation sites are
represented graphically in Figures 1, 2, 3 and 4. The day
of IgM and IgG seroconversion was similar for site of in-
oculation (p = 0.2338 and p = 1.0000, respectively). Like-
wise, no variation between the peak antibody titer for IgMFigure 1 ELISA O.D. measurements for daily IgM response in individu(p= 0.5329) and IgG (p=0.1081) was evident between the
two groups. The average onset time for an IgM response in
the clinical rabies cases was 4.0 days versus 6.0 days in the
non-clinical rabies cases (p=0.1692), while the average
onset time for an IgG response in each group was 10.0 and
16.7, respectively (p=0.0614). The average maximum anti-
body responses occurred on day 7 in the clinical rabies
cases and day 8 in the non-clinical rabies cases (p=0.7188)
for IgM and days 10.0 and 62 in the clinical rabies and
non-clinical rabies cases, respectively (p=0.0429) for IgG.
Pathology
Histology
Sections available for histological analysis were brain (6/
6), injection site (6/6), heart (5/6), and peripheral nerve
(2/6). All sections examined were histologically unre-
markable. There was neither inflammation nor Negri
bodies detected in brain tissue. Likewise, there was no
inflammation identified in the tissues of the injection
sites or the peripheral (sciatic) nerves.
Immunohistochemistry
None of the brain sections exhibited immunoreactivity
for rabies virus antibody. Canine cerebellum, positive for
rabies on IFA, was used as a positive control. Canine
sections exhibited multifocal, intracytoplasmic immu-
noreactivity of numerous neurons (data not shown).
Discussion
The objectives we sought to determine in this study were
the length of the incubation period, if a viremic stateals inoculated in the neck.
Figure 2 ELISA O.D. measurements for daily IgG response in individuals inoculated in the neck.
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mortem diagnostic tool after rabies virus infection in
night owl monkeys (Aotus nancymaae). The average
incubation period of rabies was observed as 11.5
days for the two monkeys that developed clinically
apparent disease. However, the study was terminated
at 134 days (4.5 months) post-inoculation, at which
time the remaining six study subjects did not have
clinically apparent disease. Based on this informa-
tion, it is possible the incubation period for infectionFigure 3 ELISA O.D. measurements for daily IgM response in individuin the A. nancymaae is greater than our termination
point.
The presence of viral RNA in blood and saliva
post-inoculation might suggest viremia and viral
shedding occurs, respectively, in A. nancymaae and
serve as an effective ante mortem diagnostic test;
however, no viremia or viral shedding was detected
in any of the study subjects. The PCR assay used in
this study is highly sensitive and specific for the de-
tection of rabies viral RNA [26]. Viral shedding inals inoculated in the footpad.
Figure 4 ELISA O.D. measurements for daily IgG response in individuals inoculated in the footpad.
Reaves et al. Virology Journal 2012, 9:95 Page 5 of 9
http://www.virologyj.com/content/9/1/95salivary sections presumably should occur irrespect-
ive of viremia, as rabies virus spread to glandular
tissue is unlikely to occur via blood or epithelial
cells. Previous studies have established that even
with direct rabies virus inoculation, salivary gland in-
fection is dependent on centrifugal neuronal spread
and preceding CNS involvement [27]. We would not
expect to measure viral shedding from salivary
glands without simultaneous CNS involvement
[27,28]. Our study results for the two clinical cases
show that there was no detection of viral shedding
pre-onset or post-onset of clinical symptoms; how-
ever, observation was only continued for three days
post-onset of symptoms in the clinically ill monkeys.
In contrast, viral shedding was detected in a 55-year
old patient in the U.K. using RT-PCR, but this was 4
days post-onset of symptoms [24]. Also, RT-PCR suc-
cessfully detected rabies virus in 5 saliva samples from
28 cases after the onset of symptoms [23]. Therefore,
clinical cases may have progressed too rapidly to allow
sufficient time for salivary gland infection prior to eu-
thanasia. Other possible explanations for the lack of
viral shedding include a failure of CNS involvement
and centrifugal neuronal spread in non-clinical cases,
inability of glandular cells to support infection, and im-
mune response in these monkeys. Despite the develop-
ment of serum neutralizing antibody, an inoculum
dose-related factor may also be a possibility. Studies in
foxes, dogs, and mice indicate high inoculum doses
cause rapidly progressing infections leading to death
prior to salivary gland infection [28], but this differs
from our study as there were six cases without clinical
rabies or CNS involvement.For both the lack of viremia and viral shedding,
viral neutralization, interference, and restricted infec-
tion to the site of inoculation by interferons or other
non-specific immune mechanisms may have been
factors [29]. Although these findings suggest there is
no viremia or viral shedding of rabies virus in clinic-
ally ill Aotus nancymae, it is difficult to make a con-
clusion with such a small sample size since only two
monkeys exhibited clinical symptoms. Interestingly,
this study can be used to observe the time course of
immunologic action between inoculation sites with
different distances from the CNS. The clinically ill
rabies cases were inoculated in the neck and exhib-
ited a larger and more rapid IgG antibody response
compared to the non-clinical rabies cases. Clinically
apparent disease could be caused by the brain’s
virus-specific T-cell response that fights against viral
entry into the blood brain barrier of the monkey
[30]. Since the clinically ill cases exhibited a greater
response more quickly, this could simply be indica-
tive of the virus gaining access to the CNS more
rapidly. In a study challenging mice with either an
avirulent or virulent strain of rabies, the antibody re-
sponse was higher after seven days in the avirulent
strain group, which did not develop clinical symp-
toms [31]. The prompt induction of neutralizing
antibodies, inflammation and the inhibition of viral
spread are necessary for recovery from rabies virus
[32]. Once in the CNS, the virus continually repli-
cates and leads to the onset of classical rabies symp-
toms [27]. Therefore, at the point of detection of high
antibody titers, it would be too late to clear the virus. How-
ever, if this is the case, antibody responses in the neck
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challenge should have also been high earlier; this suggests
the influence of some other factor. The overall pattern of
antibody response for the non-clinical group did not vary
significantly; however, the footpad inoculated group tended
to have a more robust initial IgM response and a prolonged
maximum IgG response compared to the neck inoculated
group. The rate of antibody response seems more import-
ant than the magnitude. A possible explanation could be
that in the footpad inoculated group, the slowly developing
antibody response allowed sufficient time to develop anti-
bodies with greater avidity and counter virus in relation to
its replication rate preventing it from entering the brain, es-
sentially preventing clinical disease. This explanation is fur-
ther supported by the fact that none of the brain tissue
sections in the non-clinically ill cases exhibited immunor-
eactivity for rabies virus or histological evidence of inflam-
mation or Negri bodies. With rabies virus infection in
humans, Negri bodies are most commonly found in the
hippocampus, pyramidal cells of the cerebral cortex, and
Purkinje cells of the cerebellum [3]. Unfortunately, brain
sections from the clinically ill rabies cases were not avail-
able for histologic and immunoreactivity analysis for
comparison.
Serological testing did provide predictive value into
the onset of disease. However, serological testing is
of limited value because seroconversion occurs late
in the course of the disease [33]. Studies in different
animal models such as mice have shown that anti-
bodies can be detected in sera [20], but this re-
sponse requires the collaboration of inflammatory
responses from B-cells and T-cells such as IFN-gamma
[30]. Skunks experimentally-infected intramuscularly
with wild-type rabies developed a detectable neutral-
izing antibody response 7–12 days post- inoculation
but not without CNS involvement[27]. One study
has shown that virus-neutralizing antibodies for ra-
bies can be developed around 122 days after vaccin-
ation in capuchin monkeys using suckling mouse
brain rabies vaccine [34]. Virus-neutralizing antibody
detected in the serum can only really indicate expos-
ure to the rabies virus; the outcome of the invasion
relies on a complex interplay of viral and host fac-
tors [35]. Antibody immune response following viral
inoculation relies on the replication of virus in ani-
mal tissue, in contrast to response from high levels
of viral particles in commonly used inactivated vac-
cines [29]. However, serum neutralizing antibodies in
our study were likely in response to viral antigen in
the original inoculum since immunoflorescence was
not detected in any pathology tissue, including the
sites of infection. Extraneuronal infection in muscle is short
lived, being eliminated by immune response [27,28]. This
may explain the negative immunofluorescence findings attissue inoculation sites since pathology testing was not done
until 134 days post inoculation.
Conclusion
The antibody responses of eight challenged Aotus nancy-
maae, owl monkeys, were successfully observed. Under-
standing the natural immune response to rabies antigen
can facilitate future development of prophylactic vaccin-
ation [36]. This study suggests a viremic state does not
exist with rabies infection in New World NHP; however,
more studies are needed to develop ante mortem, prac-
tical diagnostics for rabies infection. The lack of viral
shedding in experimentally-infected owl monkeys is yet
to be explained and more importantly does not necessar-
ily indicate salivary excretions are noninfectious. Owl
monkeys may be able to be reproducibly infected with
rabies virus but does not serve as a suitable model for
infection and immunogenicity for the evaluation of can-
didate vaccines against rabies. It is also notable that 6 of
the 8 challenged monkeys survived infection, at least up
to 134 days post inoculation. One study has previously
shown that other species may have evidence of rabies in-
fection and clearance of the virus without clinical symp-
toms of disease [37], although this may be explained by a
less virulent strain of the virus [3]. There is an inherent risk
in generalizing results between different animal reservoirs
as the complete picture of how rabies virus operates largely
remains a mystery in many mammal species. Additional
studies that address the limitations of sample size, length of
observation, and lack of measurable infection should be
conducted to better understand the natural history of rabies
in New World NHP species.
Methods
Aotus nancymaae, New World owl monkeys
This animal study was approved by the Naval Medical
Research Unit SIX (NAMRU-6) Institutional Animal
Care and Use Committee and the Department of the
Navy Bureau of Medicine and Surgery. Owl monkeys
(Aotus nancymaae) were obtained from the Instituto
Veterinario de Investigaciones Tropicales y de Altura,
Universidad Nacional Mayor de San Marcos (San Mar-
cos University), Peru and approved for use by the
attending veterinarian. NAMRU-6 is a facility accredited
by the Association for Assessment and Accreditation of
Laboratory Animal Care, International; therefore all hus-
bandry and experimental procedures were conducted in
compliance with the Animal Welfare Act and The Guide
for the Care and Use of Laboratory Animals [38]. All
animals were singly housed in standard metal cages with
nest boxes, perches, and manipulanda. A commercially
formulated monkey diet (New World Primate Diet
8794 N, Harlan Teklad, Madison, WI) was provided
daily and supplemented with small quantities of fresh fruit
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tum. Animals were provided a reverse 12:12-hour light:
dark cycle that was offset from the normal day so that
monkeys could be observed during their active time. The
eight A. nancymaae monkeys randomly selected for this
study were greater than 1-year age, had a weight greater
than 1000 g, and showed negative tuberculosis tests within
the 6 months preceding the study. Each animal was indi-
vidually identified by a tattoo placed on the abdomen.
Animals were anesthetized with ketamine hydrochlor-
ide (10 mg/kg) injected intramuscularly in the caudal
thigh (26 gauge, 3/4-1 inch needle). This was performed
for restraint during procedures such as viral inoculation,
blood withdrawal, and cheek swab. Blood samples were
collected from either the femoral or saphenous vein
using a 26 gauge ½ inch needle and cheek swabs were
collected using a sterile cotton swab rubbed against the
inner surface of the cheek to obtain saliva. Animals were
humanely euthanized by injection of T-61 (0.5 ml/Kg
BW) IV or intracardiac using a 23 gauge, 1 inch or 21
gauge, 1 ½ inch needle after being anesthetized for
restraint.Virus
Rabies virus used for this study was derived from rabies
vaccine strain, (Pasteur)/V-13R. Viral inoculum was pre-
pared from a cell culture lysate and clarified by centri-
fuge at 800 g.Animal challenge
A total of 8 monkeys were randomly assigned to two
groups (n = 4) for inoculation intramuscularly (IM), ei-
ther in the footpad or the neck, to account for differ-
ences due to wound site in relation to nerve supply and
distance from the brain. Each monkey received 1.0 × 105
pfu of rabies virus from 0.2-0.4 ml of viral inoculum.
Group I animals were inoculated IM in the neck muscu-
lature. Group II animals were inoculated in the plantar
surface of the right foot.
A daily 0.8 ml blood sample and cheek swab were col-
lected starting 24-hours after inoculation and continued
for 10 days. Baseline samples were collected at day −7
(± 3 days). After the initial 10 days post-inoculation,
each blood sample and cheek swab were collected every
3 days until the onset of clinical symptoms. At the onset
of symptoms, a 0.8 mL blood sample was taken and
repeated daily for two days. On the third day of symp-
toms, a terminal 20 ml blood sample was collected and
the monkey was euthanized.
To assess serologic response and viremia, blood sam-
ples were analyzed for serum neutralizing antibody titers
by ELISA and for viremia by RT-PCR and viral isolation,followed by RT-PCR and sequencing. Cheek swabs were
tested for rabies virus by RT-PCR and viral isolation.
IgM and IgG ELISA
Monkey sera were analyzed for anti-Rabies IgM or IgG
antibodies using an in-house ELISA. Briefly, the ELISA
test uses antihuman antibody coated plates where each
serum sample is added at a concentration of 1/100.
These are then incubated at 37°C for 60 minutes with
viral antigen. After washing, hyperimmune mouse ascitic
fluid (HMAF) is added and incubated and washed again.
HRP labled goat anti-mouse IgG+M (H+L) conjugate
is then added to each sample, incubated and washed.
Samples are read at 450 nm.
RT-PCR
RNA viral extraction was performed from monkey sera
diluted with Trizol following the manufacturer protocol.
5ul of RNA plus 1.25ul primers 1066 (10 mM) were
added in a PCR tube. The solution was heated to 90°C
for 2 min and cooled on ice for 5 min. 43.75 ul of RT-
PCR master mix was added containing 0.25ul of primers
1066 (40 mM) and 1.25ul of primer 304 (20 mM); 5ul of
10X PCR buffer with MgCl2; 4ul of dNTPs 2.5 mM;
DTT (1 M); 0.4ul of AMV reverse transcriptase (15U/
ul); 0.4ul of Taq polymerase (5U/ul); and 32.2ul of Nu-
clease free water. The PCR conditions were: 42°C
90 min; 94°C x 3 min following of 45 cycles of 94°C x
30 sec; 37°C x 40 sec; 72°C x 90 sec; and a extension of
72°C x 10 min; kept at 4°C. 8 ul of RT- PCR were used
for electrophoresis on 2% agarose gels and visualized by
ethidium bromide staining.
Viral isolation
Virus from blood and saliva samples was prepared for
isolation in Vero cells. The inoculums were allowed to
absorb at 37°C for 60 min in a 5% CO2 humidified incu-
bator and kept in maintenance media (2% fetal bovine
serum - FBS) in a plate or flask. Cells were incubated at
37°C in 5% CO2 for 10 days. Cells were observed daily
for cytopathic effects (CPE). After 10 days, an immuno-
fluorescence assay (IFA) for FITC Anti-rabies Monoclo-
nal Globulin was conducted.
Pathology
Histology
Routine histological analysis was conducted on tissue
sections of whole brain, injection site, heart, and periph-
eral (sciatic) nerve. Three sections of brain from each
non-human primate were prepared and examined, which
included the hippocampus, pyramidal cells of the cere-
bral cortex, and Purkinje cells of the cerebellum. Brain
tissue was taken at 25 mm and 5 mm caudal to and
10 mm cranial to the anterior commissure. Tissues were
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H&E.
Immunohistochemistry
Immunohistochemical detection of rabies virus (glyco-
protein of rabies virus) was performed on sections of
formalin fixed, paraffin embedded blocks of non-human
primate cerebrum. Slides were deparaffinized using xy-
lene followed by graded baths of ethanol. A DAKO
Autostainer Plus Universal Staining System (DAKO,
Carpenteria, CA) was used for the automated immuno-
histochemical staining. Antigen retrieval was performed
using Citra (BioGenex, San Ramon, CA) for 30 minutes.
Mouse monoclonal antibody to rabies virus (Abcam,
Cambridge, MA) was used at a dilution of 1:500 and
incubated overnight at 4 C. LSAB2-HRP dual anti-
rabbit/anti-mouse (DAKO, Carpenteria, CA) was applied
ready to use as a secondary antibody for 30 minutes at
room temperature. The chromogen applied was 3, 3’
Diaminobenzidine (DAKO, Carpenteria, CA). The sec-
tions were counterstained with Hematoxylin (DAKO,
Carpenteria, CA) and then coverslipped.
Data analysis
All data analysis was performed using Stata/SE 11.1 for
Windows (StataCorp LP, College Station, TX). Life
tables for survival analysis were used for evaluation of
seroconversion levels of antibodies. Wilcoxon rank-sum
non-parametric test was used to assess average time to
seroconversion and maximum antibody levels between
clinically ill and non-clinically ill cases as well as to test
differences in the site of inoculation. Significance levels
were considered as the standard <0.05.
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